Inspire Medical Stock Performance
Inspire Medical (ticker: INSP) closed the trading session on Friday 23 November 2023 at a price of USD 72.66. The share price declined 0.38 % during the 24‑hour period ending at 04:05 AM Central Europe time.
- Current market capitalization: USD 2.1 billion
- Shares outstanding: 28.9 million
- Volume traded in the last 24 hours: USD 39.4 million
Since the end of the previous month, the share price has fallen 0.32 %.
The 200‑day simple moving average (SMA) is USD 59.45. The 52‑week high reached USD 147.03 on 10 December 2025, and the 52‑week low was USD 38.91 on 3 June 2026.
Performance of Related Stocks
| Stock | Recent 24‑hour change | Current price | Market cap | P/E ratio |
|---|---|---|---|---|
| Quantumscape (QS) | 0 % | USD 4.15 | USD 2.5 billion | — |
| First Busey (BUSE) | –0.43 % | USD 30.63 | USD 2.5 billion | 12.46 |
| Dxc (DXC) | +5.26 % | USD 16.08 | USD 2.5 billion | 20.62 |
| Kohls (KSS) | +1.93 % | USD 24.78 | USD 2.5 billion | 9.26 |
| Precigen (PGEN) | –3.37 % | USD 6.39 | USD 2.5 billion | — |
Company Overview
Inspire Medical Systems, Inc. is a U.S.‑based medical technology company that develops implantable neurostimulation systems for the treatment of obstructive sleep apnea. The company aims to improve sleep quality and overall health for patients by providing innovative neurostimulation solutions. Inspire Medical went public on 5 May 2018 via listing on the New York Stock Exchange.
